“First results of the prospective ETiCS-study: acute (microbial-associated) inflammation rather than (infarction-associated) myocardial ischemia triggers the development of cardiac GPCR autoantibodies”, Adv. RAB Res., vol. 1, no. 1, p. Advances in RAB Research, Vol 1, No 1, 2018 –, Sep. 2018, doi: 10.18416/RAB.2018.1809021.